Jean-Pierre Bourquin

18PUBLICATIONS
130CO-AUTHORS
Haematological tumoursGene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsAdolescent health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|May 06, 2026
TCF3::HLF orchestrates an enhancer-promoter network with activation of MEF2C to promote immature HSC gene expression in leukemia.

|Mar 27, 2026
IGH::FENDRR and specific KRAS mutations define a novel B-ALL molecular subtype with poor chemotherapy response.

Sonja Bendig, Alina M Hartmann, Wiebke Wessels

|Nov 10, 2025
Reducing Daunorubicin in Induction Therapy in Children With B-Lineage ALL With Favorable Prognosis: Results of Phase III Trial AIEOP-BFM ALL 2009.

Hanna Gottschalk, Anja Möricke, Valentino Conter

|Sep 10, 2025
A three-dimensional ex vivo model recapitulates in vivo features and drug resistance phenotypes in childhood acute lymphoblastic leukemia.

Magdalini Kanari, Iria Jimenez Garcia, Fabio D Steffen

|Aug 21, 2025
Patient-derived tumoroids from CIC::DUX4 rearranged sarcoma identify MCL1 as a therapeutic target.

Willemijn Breunis, Eva Brack, Anna C Ehlers

|Jun 27, 2025
Role of stem-like cells in chemotherapy resistance and relapse in pediatric T-cell acute lymphoblastic leukemia.

Julia Costea, Kerstin K Rauwolf, Pietro Zafferani

Pageof 3

Frequent Collaborators

7 joint publications

Beat C Bornhauser

4 joint publications

Fabio Steffen

3 joint publications

Franco Locatelli

3 joint publications

Cornelia Eckert